Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial

Authors not listed

Shahid Beheshti University of Medical Sciences · 2005

Abstract

The purpose of this study is to compare the efficacy and safety of intravitreal injection of bevacizumab alone versus bevacizumab combined with triamcinolone for treatment of refractory diabetic macular edema.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-02 MST

Cite this

APA
Anonymous. (2005). Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial. <em>Shahid Beheshti University of Medical Sciences</em>. https://clinicaltrials.gov/study/NCT00370422
Vancouver
Anonymous. Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial. Shahid Beheshti University of Medical Sciences. 2005.
BibTeX
@misc{anon2005Bevaci, title = {Bevacizumab Versus Combined Bevacizumab and Triamcinolone for Refractory Diabetic Macular Edema; a Randomized Clinical Trial}, author = {Anonymous}, journal = {Shahid Beheshti University of Medical Sciences}, year = {2005}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings